Clinical Scorecard: The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol

At a Glance

Key Highlights

• No evidence supports the use of phthalates in softgel capsules.
• Softgel capsules primarily use glycerin and sorbitol as plasticizers.
• Low molecular weight phthalates are approved for use in tablets and powder-filled capsules, not softgels.
• Consumers can verify phthalate use by checking ingredient listings.
• Recent studies show no association between softgel consumption and elevated urinary phthalate levels.
• Phthalates are not used in softgel capsules, ensuring no significant health risks.

Guideline-Based Recommendations

Diagnosis

• Assess potential phthalate exposure from various pharmaceutical forms, noting that softgels do not contain phthalates.

Management

• Encourage consumers to check ingredient lists for phthalate presence, emphasizing that softgels are phthalate-free.

Monitoring & Follow-up

• Monitor emerging studies on phthalates and health risks, particularly regarding softgel capsules.

Risks

• High molecular weight phthalates are associated with health risks, but not from softgel capsules.

Patient & Prescribing Data

Softgels are safe and do not pose a significant risk of phthalate exposure, as they do not contain phthalates.

Clinical Best Practices

• Educate patients on verifying ingredient safety in supplements, specifically regarding the absence of phthalates in softgels.
• Stay updated on research regarding phthalates and health implications, particularly in relation to softgel capsules.

References

• FDA Inactive Ingredient Database
• 2021 Study on Phthalates and Heart Attacks
• 2019 Study on Fish Oils and Phthalates